MLTX
MoonLake Immunotherapeutics
3월 13일 4:00 PM ET (한국 3/14 05:00)
$17.13
+0.10 ▲ +0.59%
🌙 3월 13일 7:44 PM ET (한국 3/14 08:44)
$17.31
+0.18 ▲ +1.05%
| Index | - | P/E | - | EPS (ttm) | -3.53 | Insider Own | 12.29% | Shs Outstand | 0.07B | Perf Week | -5.62% |
| Market Cap | 1.23B | Forward P/E | - | EPS next Y | -3.28% | Insider Trans | -43.88% | Shs Float | 0.06B | Perf Month | 8.49% |
| Enterprise Value | 0.91B | PEG | - | EPS next Q | -0.91 | Inst Own | 78.05% | Short Float | 11.18% | Perf Quarter | 17.25% |
| Income | -0.23B | P/S | - | EPS this Y | -1.43% | Inst Trans | 26.48% | Short Ratio | 3.46 | Perf Half Y | -68.45% |
| Sales | 0.00B | P/B | 4.02 | EPS next 5Y | 11.82% | ROA | -50.38% | Short Interest | 7.04M | Perf YTD | 29.97% |
| Book/sh | 4.27 | P/C | 3.12 | EPS past 3/5Y | -27.48% -256.78% | ROE | -60.51% | 52W High | -72.7% ($62.75) | Perf Year | -54.71% |
| Cash/sh | 5.49 | P/FCF | - | Sales past 3/5Y | - | ROIC | -59.99% | 52W Low | 187.9% ($5.95) | Perf 3Y | -22.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -86.55% | Gross Margin | - | Volatility(W/M) | 5.18% 5.6% | Perf 5Y | 59.65% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.93 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.27 | EPS Q/Q | -27.4% | Profit Margin | - | RSI (14) | 48.22 | Recom | 1.86 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.27 | Sales Q/Q | - | SMA20 | -4.12% ($17.87) | Beta | 1.25 | Target Price | $29.69 |
| Payout | - | Debt/Eq | 0.25 | Earnings | 2000000 | SMA50 | 4.62% ($16.37) | Rel Volume | 0.33 | Prev Close | $17.03 |
| Employees | 130 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | 3.86% - | SMA200 | -42.2% ($29.64) | Avg Volume(3M) | 2.03M | Price | $17.13 |
| IPO | 2020/10/20 | Option/Short | Yes/Yes | Trades | 10122 | Volume | 679,107 | Change | 0.59% |
뉴스 로딩 중...